SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-054261
Filing Date
2021-11-04
Accepted
2021-11-04 08:10:55
Documents
57
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atra-10q_20210930.htm   iXBRL 10-Q 2885694
2 EX-10.1 atra-ex101_82.htm EX-10.1 30670
3 EX-31.1 atra-ex311_8.htm EX-31.1 16112
4 EX-31.2 atra-ex312_7.htm EX-31.2 16144
5 EX-32.1 atra-ex321_9.htm EX-32.1 8038
  Complete submission text file 0001564590-21-054261.txt   7968810

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atra-20210930.xsd EX-101.SCH 51833
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atra-20210930_cal.xml EX-101.CAL 46956
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atra-20210930_def.xml EX-101.DEF 153529
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20210930_lab.xml EX-101.LAB 387386
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20210930_pre.xml EX-101.PRE 276108
11 EXTRACTED XBRL INSTANCE DOCUMENT atra-10q_20210930_htm.xml XML 1259556
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 211378126
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences